Susana Hernández

522 total citations
32 papers, 276 citations indexed

About

Susana Hernández is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Susana Hernández has authored 32 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Susana Hernández's work include Lung Cancer Treatments and Mutations (12 papers), Cancer Genomics and Diagnostics (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Susana Hernández is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Cancer Genomics and Diagnostics (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Susana Hernández collaborates with scholars based in Spain, United States and Italy. Susana Hernández's co-authors include Fernando López‐Ríos, Esther Conde, Rebeca Martínez, Marta Alonso de la Varga, Luis Jesús Jiménez‐Borreguero, Fernándo Alfonso, Carmen Quereda, Elena Eyre, Santiago Moreno and Beatriz Mahíllo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Susana Hernández

27 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susana Hernández Spain 9 132 110 51 49 43 32 276
Nicola Susca Italy 9 84 0.6× 84 0.8× 63 1.2× 30 0.6× 44 1.0× 20 325
Xia He China 10 132 1.0× 173 1.6× 58 1.1× 14 0.3× 59 1.4× 13 322
Hans Joerg Mischinger Austria 11 91 0.7× 126 1.1× 44 0.9× 19 0.4× 24 0.6× 23 321
Francesca Marcon United Kingdom 12 103 0.8× 264 2.4× 59 1.2× 27 0.6× 31 0.7× 21 440
Akihiro Okano Japan 10 149 1.1× 64 0.6× 20 0.4× 24 0.5× 57 1.3× 43 357
Till Ploenes Germany 11 248 1.9× 99 0.9× 44 0.9× 12 0.2× 36 0.8× 44 395
P. Audet Canada 8 182 1.4× 60 0.5× 54 1.1× 38 0.8× 53 1.2× 10 327
Li Xie China 9 227 1.7× 70 0.6× 45 0.9× 16 0.3× 35 0.8× 23 433
Erik Škof Slovenia 11 48 0.4× 173 1.6× 44 0.9× 21 0.4× 12 0.3× 34 347
Makoto Kadokura Japan 13 93 0.7× 215 2.0× 74 1.5× 10 0.2× 105 2.4× 41 397

Countries citing papers authored by Susana Hernández

Since Specialization
Citations

This map shows the geographic impact of Susana Hernández's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susana Hernández with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susana Hernández more than expected).

Fields of papers citing papers by Susana Hernández

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susana Hernández. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susana Hernández. The network helps show where Susana Hernández may publish in the future.

Co-authorship network of co-authors of Susana Hernández

This figure shows the co-authorship network connecting the top 25 collaborators of Susana Hernández. A scholar is included among the top collaborators of Susana Hernández based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susana Hernández. Susana Hernández is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alborelli, Ilaria, Melanie Demes, Peter J. Wild, et al.. (2025). ERBB2 Mutation Testing in NSCLC: A Pan-European Real-World Evaluation of the Oncomine Precision Assay. SHILAP Revista de lepidopterología. 6(3). 19–19.
2.
Cabo, Horacio, Esther Conde, Susana Hernández, et al.. (2024). Clinical Utility of Combined Tissue and Plasma Next-Generation Sequencing in Patients With Advanced, Treatment-Naïve NSCLC. JTO Clinical and Research Reports. 6(3). 100778–100778.
3.
Brandes, Alissa, A. Koo, Kathryn Michels, et al.. (2024). Nonclinical Toxicology, Biodistribution, and Pharmacokinetics of UB-VV111, an In Vivo Anti-CD19 CAR T Cell Therapy. Blood. 144(Supplement 1). 2046–2046. 1 indexed citations
4.
Hernández, Susana, et al.. (2024). Assessment of PD-L1 expression and tumour infiltrating lymphocytes in early-stage non-small cell lung carcinoma with artificial intelligence algorithms. Journal of Clinical Pathology. 78(7). 456–464. 3 indexed citations
5.
Hernández, Susana, Esther Conde, Marta Alonso de la Varga, et al.. (2023). A narrative review of methods for the identification of ALK fusions in patients with non-small cell lung carcinoma. Translational Lung Cancer Research. 12(7). 1549–1562. 8 indexed citations
6.
Brandes, Alissa, Susana Hernández, Christopher J. Nicolai, et al.. (2023). 438 In vivo Engineered CAR-T cells for oncology using a surface-engineered lentivirus platform: nonclinical safety and biodistribution. SHILAP Revista de lepidopterología. A487–A487. 1 indexed citations
7.
Conde, Esther, Susana Hernández, Javier Baena, et al.. (2023). Comparison between liquid biopsy and tissue NGS in two cohorts of advanced NSCLC.. Journal of Clinical Oncology. 41(16_suppl). e21043–e21043.
8.
Conde, Esther, Susana Hernández, Elena Eyre, et al.. (2020). Pan-TRK Immunohistochemistry: An Example-Based Practical Approach to Efficiently Identify Patients With NTRK Fusion Cancer. Archives of Pathology & Laboratory Medicine. 145(8). 1031–1040. 28 indexed citations
9.
Remón, Jordi, Maria Teresa Rodrigo‐Calvo, Raquel Martín, et al.. (2020). Cystic Brain Metastases Revealed Patient With RET-Rearranged Non–Small-Cell Lung Cancer With Leptomeningeal Carcinomatosis and RET-Positive in CSF. JCO Precision Oncology. 4(4). 1–5. 1 indexed citations
10.
Yang, Jessica, Marlana Orloff, Joseph J. Sacco, et al.. (2019). Resensitization of uveal melanoma (UM) to immune checkpoint inhibition (ICI) by IMCgp100 (IMC).. Journal of Clinical Oncology. 37(15_suppl). 9592–9592. 4 indexed citations
11.
Shu, Catherine A., Claud Grigg, Codruța Chiuzan, et al.. (2018). Neoadjuvant atezolizumab + chemotherapy in resectable non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 36(15_suppl). 8532–8532. 31 indexed citations
12.
Hernández, Susana, Esther Conde, Rebeca Martínez, et al.. (2017). P1.02-043 Multiplexed FISH (ALK/ROS1, RET, NTRK1) in Lung Adenocarcinomas: Novel Dual ALK/ROS1 Probe and Automated Scanning System. Journal of Thoracic Oncology. 12(1). S513–S514. 1 indexed citations
13.
Conde, Esther, et al.. (2016). Profile of Ventana ALK (D5F3) companion diagnostic assay for non-small-cell lung carcinomas. Expert Review of Molecular Diagnostics. 16(6). 707–713. 37 indexed citations
14.
Gómez, Ana María, José Antonio López García‐Asenjo, Cristina Fernández, et al.. (2014). Relationship of immunohistochemical biomarker expression and lymph node involvement in patients undergoing surgical treatment of NSCLC with long-term follow-up. Tumor Biology. 35(5). 4551–4559. 4 indexed citations
15.
Zugazagoitia, Jon, Javier Puente, J.L. González-Larriba, et al.. (2013). Erlotinib versus Pemetrexed for Pretreated Non-Squamous Non-Small Cell Lung Cancer Patients in Clinical Practice. Oncology. 84(5). 255–264. 6 indexed citations
16.
Sereno, María, Maria J. Merino, Cristina Aguayo, et al.. (2013). A major response to trabectedin in metastatic malignant fibrous histiocytoma of the vertebra: a case report and review of the literature.. PubMed. 99(2). e43–8. 3 indexed citations
17.
18.
Arias, Luis Fernando, et al.. (2008). Estudios auxiliares en el diagnóstico diferencial de tumores epiteliales renales con células granulares. Actas Urológicas Españolas. 32(2). 194–201.
19.
Álvarez, Teresa, Javier Sanz, Ana Sánchez‐Fructuoso, et al.. (2004). [BK virus in kidney allografts: a search for histologic evidence of the infection].. PubMed. 24(5). 480–5. 3 indexed citations
20.
Arias, Luis Fernando, Susana Hernández, Dolores Prats, et al.. (2003). Epstein-Barr virus latency in kidney specimens from transplant recipients. Nephrology Dialysis Transplantation. 18(12). 2638–2643. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicola Susca Breakdown of academic impact, for papers by Xia He Breakdown of academic impact, for papers by Hans Joerg Mischinger Breakdown of academic impact, for papers by Francesca Marcon Breakdown of academic impact, for papers by Akihiro Okano Breakdown of academic impact, for papers by Till Ploenes Breakdown of academic impact, for papers by P. Audet Breakdown of academic impact, for papers by Li Xie Breakdown of academic impact, for papers by Erik Škof Breakdown of academic impact, for papers by Makoto Kadokura
Rankless by CCL
2026